DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Megace ES (Megestrol) - Infection in AN Immunocompromised Host - Suspected Cause - Side Effect Reports


Index of reports > Cases with Infection in AN Immunocompromised Host (1)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Megace ES (Megestrol) where reactions include infection in an immunocompromised host. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Megace ES side effects in

Reported by a individual with unspecified qualification from United States on 2012-06-22


Reactions: Death, Endometritis, Unresponsive To Stimuli, Mental Status Changes, Immunodeficiency, Infection in AN Immunocompromised Host

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Megace ES
    Dosage: 625 mg/ 5 ml, once daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-15
    End date: 2012-06-06

Tramadol HCL
    Dosage: 50 mg, tid
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Prilosec; Niferex; Colace; Lisinopril; Calcium Replacement

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017